Celerion is the First CRO Headquartered in the USA to Receive Full Accreditation From AAHRPP

Published: Sep 17, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, the premier provider of innovative early stage drug development solutions, is pleased to announce that it has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP). Celerion’s clinical facilities in the USA; Lincoln NE; Neptune NJ; and Phoenix AZ, have achieved this significant milestone.

Back to news